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Three independent experiments showed similar results to this gel.
Figure S2. Physiological effects of the new spacers on host cells. (A)
Virus resistance was provided by new spacers, with a 10 6 -to 10 7 -fold drop in PFU/ml during plaque assay. We selected three individual colonies (VIM10, VIM25, and VIM45) each containing one new spacer for analysis. VIM, virus insensitive mutant.
(B) More new spacers were acquired during HHPV-2 re-infection. M, dsDNA size marker.
Figure S3. Validation of the genotype of cas mutants and CRISPR variants. (A)
PCR analysis was performed against genomic DNA from each cas mutant (mut) with the UF/DR primers. For Δcas1, Δcas2, Δcas3, and Δcas4 mutants, genomic DNA from DF60 was used as a negative control (wt), while for Δcas5-8, the knockout plasmid pDCAS5-8 was also subjected to PCR amplification as a positive control (pls). The smaller products (~1.
kb) indicate the absence of the target cas gene(s). (B)
Validation of the Δcas5-8 mutant (mut) by confirming the absence of the cas5h gene. DF60 genomic DNA was subjected to PCR amplification as a positive control (wt). The primer pair Cas5h-test-F/R was used. (C) PCR analyses against genomic DNA from DF60 and CRISPR variants with the DSP-UF/DSP-DR primers. The wild-type CRISPR in DF60 generated a 2.10-kb PCR product, and PCR products with smaller MWs were produced from the variant CRISPRs of Δsp1-14 (~1.31 kb), Δsp2-6 (~1.83 kb), Δsp7-13 (~1.71 kb), Δsp2-12 (~1.45 kb), Δsp2-13 (1.38 kb), and Δsp13 (~2.03 kb). Lane Ms, dsDNA size markers. The PCR primers are listed in Supplementary  Table S2 . The residues replaced by alanine for point mutation were indicated with black arrows and their positions within H. hispanica Cas3 sequence. His20, His55, and Asp56 are putative key residues in the HD-type nuclease domain, while Asp229, Lys315, Asp439, and Glu440 are putative key residues in the DExD/H helicase domain (1 Table S2 . Oligonucleotides used in this study
GCAGAACATTCTGACTCATT genome-seq-5R TCAGCTCATACGACCGAGAC genome-seq-6F TCGGGTCCGGTCTGATC genome-seq-6R CGAACAGACGACGATTCAGT a Each spacer is designated with a 'v' (indicating virus-derived) followed by two numbers (separated by a dot). The first is the colony number, and the second indicates its location within the expanded array according to the leader (e.g. "v1.1" is the most recently acquired spacer in colony1). b The positions of protospacers (from which a spacer was derived) on the HHPV-2 genome. c "+" and "-" correspond respectively to the coding strand and the template strand of the rep gene (ORF1). d The C in parenthesis is the first nucleotide of the following protospacer. a Each spacer is designated with a 'p' (indicating plasmid-derived) followed by two numbers (separated by a dot). The first is the colony number, and the second indicates its location according to the leader (e.g. "p1.1" is the most recently acquired spacer in colony1). b The positions of protospacers (from which a spacer was derived) on the target plasmid pVS. The fourth nucleotide of the unique SphI restriction site was taken as the first position. The priming spacer13 imperfectly matches to the nucleotides 7209-7245. c "+" and "-" correspond respectively to the coding strand and the template strand of the pyrF gene. a The HHPV-2 genome or pVS was artificially divided into three regions (depicted in Figure 6 of the main text)
For spacer acquisition assay
according to the strand bias during spacer acquisition. The non-target strand and target strand of the priming protospacer respectively correspond to the coding strand and the template strand of the rep gene (HHPV-2) or the pyrF gene (pVS). b (+) or (-) indicates the location on the coding or template strand of the rep gene (HHPV-2) or the pyrF gene (pVS). 
